In August 2025, the company announced that the insights gained would form the basis for its market entry into the longevity sector starting in 2026
those with a lower BMR will have more difficulty burning calories, which makes losing weight more challenging
It was also reported that co-inheritance of a uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) gene variant is an added risk factor for neonatal hyperbilirubinemia in G6PD-deficient male neonates (69)
It is not intended for cosmetic fat removal and requires medical supervision
It may also reduce the risk of heart attack, stroke and other serious complications of type 2 diabetes or heart or blood vessel disease
Exenatide Overview : Exenatide, like semaglutide, is a GLP-1 receptor agonist used for diabetes management Pros : Effective for blood sugar control and potential weight loss Cons : Requires injections, and it may have side effects 5